{"url":"https://lda.senate.gov/api/v1/filings/2fed8e42-e178-4d7c-85dc-2e034d62daac/","filing_uuid":"2fed8e42-e178-4d7c-85dc-2e034d62daac","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2fed8e42-e178-4d7c-85dc-2e034d62daac/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jordan Cox","dt_posted":"2025-01-13T14:48:26-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"77 4th Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02451","registrant":{"id":401105953,"url":"https://lda.senate.gov/api/v1/registrants/401105953/","house_registrant_id":null,"name":"REVVITY, INC.","description":"Provides products and services for Life Sciences/Diagnostics.","address_1":"77 4th Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02451","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUIS M. TOVAR","contact_telephone":"+1 774-422-9041","dt_updated":"2026-07-10T13:42:56.425475-04:00"},"client":{"id":208897,"url":"https://lda.senate.gov/api/v1/clients/208897/","client_id":12,"name":"REVVITY, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":93728,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"COX","suffix":null,"suffix_display":null},"covered_position":"Sr. Advisor, Office of the Asst Secretary for Legislation, US Dept. of Health & Human Services, Sr. Legislative Asst, US Representative Vicky Hartzler, Legislative Aide, US Senator Deb Fischer, Legislative Aide, US Representative John R. Carter","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}